Saturday, May 15, 2021
ADVT 
International

AstraZeneca resuming US testing of COVID-19 vaccine

Darpan News Desk The Canadian Press, 23 Oct, 2020 09:31 PM
  • AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca Inc. announced Friday that regulators are letting it resume testing of its COVID-19 vaccine candidate in the U.S.

Testing of the vaccine was halted worldwide early last month because of a British study volunteer’s illness. Studies have already resumed in other countries, and the British drugmaker said the Food and Drug Administration gave the company the go-ahead Friday to resume U.S. testing.

The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

The drugmaker said it was allowed to resume testing after the FDA “reviewed all safety data from trials globally and concluded it was safe to resume the trial.”

The company said that testing has already resumed in the United Kingdom, Brazil, South Africa and Japan.

Such temporary halts of drug and vaccine testing are relatively common, because in research involving thousands of participants, some are likely to fall ill. Putting a study on hold allows researchers to investigate whether an illness is a side effect or a coincidence.

AstraZeneca's study in the U.S. involves 30,000 people, with some getting the vaccine and others a dummy shot.

Testing was stopped after one participant in the United Kingdom developed severe neurological symptoms consistent with a rare inflammation of the spinal cord called transverse myelitis. It was the second hold in AstraZeneca testing.

MORE International ARTICLES

CDC drops controversial testing advice that caused backlash

CDC drops controversial testing advice that caused backlash

The CDC now says anyone who has been within 6 feet of an infected person for at least 15 minutes should get a test.

CDC drops controversial testing advice that caused backlash

US outlines sweeping plan to provide free COVID-19 vaccines

US outlines sweeping plan to provide free COVID-19 vaccines

Since the poll, questions have only mounted about whether the government is trying to rush treatments and vaccines to help President Donald Trump's reelection chances.

US outlines sweeping plan to provide free COVID-19 vaccines

Seeping under doors, bad air from West's fires won't ease up

Seeping under doors, bad air from West's fires won't ease up

People in Oregon, Washington state and California have been struggling for a week or longer under some of the most unhealthy air on the planet.

Seeping under doors, bad air from West's fires won't ease up

Cyprus police probe tossing of chickens, rabbits at school

Cyprus police probe tossing of chickens, rabbits at school

The high school's principal filed a complaint about the actions involving the rabbits and chickens, and several students have been questioned, the police spokesman said.

Cyprus police probe tossing of chickens, rabbits at school

Pew poll finds Canada's view of U.S. at record low

Pew poll finds Canada's view of U.S. at record low

The finding tracks an identical trend among all 13 countries involved in the poll — record lows were also recorded in the U.K., France, Germany, Japan and Australia.

Pew poll finds Canada's view of U.S. at record low

Macy's plans smaller but camera-ready Thanksgiving parade

Macy's plans smaller but camera-ready Thanksgiving parade

Macy's similarly remade its traditional July Fourth fireworks show this year, swapping the big one-night spectacle for a series of smaller fireworks displays.

Macy's plans smaller but camera-ready Thanksgiving parade